-
What happened to all the projects that Applied Biosystems had going before the purchase?
FORBES: Should Life Technologies Go Private?
-
The current market cap is now worth less than the amount of the Applied Biosystems purchase.
FORBES: Should Life Technologies Go Private?
-
Two other biotechs, Applied Biosystems and Helicos, are planning to roll out their own machines.
FORBES: Magazine Article
-
Celera and Applied Biosystems are both tracking stocks for a larger corporation called Applera .
FORBES: Magazine Article
-
Illumina, Applied Biosystems and Helicos Biosciences are among the other players making or developing next-generation gene sequencers.
FORBES: Magazine Article
-
Orchid Biosystems has stood out since its IPO in early May.
FORBES: Orchid Biosciences Not Yet In The Black
-
What the company offers is compatibility between its technology and that provided by partners like Affymetrix and PE Biosystems peb (nyse: peb - news - people).
FORBES: Orchid Biosciences Not Yet In The Black
-
Solving this problem is the first order of business for T2 Biosystems, a company founded on the strength of a new diagnostic technology developed by scientists at MIT and Massachusetts General Hospital.
FORBES: MIT Spinoff, T2 Biosystems, Hopes To Slash Deadly Hospital Infection Deaths
-
Roche's 454 Life Sciences unit, the biotech Illumina and Applied BioSystems have all introduced new gene sequencers that are far cheaper and faster than the ones that sequenced Venter's genes, but also less exacting.
FORBES: All Mapped Out
-
Thus the genome project would come to rely on new machines from lab equipment maker Applied Biosystems, which industrialized the process of counting these DNA letters, using tiny glass tubes that sorted DNA fragments by length.
FORBES: On The Cover/Top Stories
-
According to Dr Tamanaha, the laboratory has developed a portable, battery-powered unit the size of a shoebox, and has licensed its technology to Seahawk Biosystems, a firm based in Austin, Texas, for food-testing and environmental applications.
ECONOMIST: Labs on a chip
-
Life Technologies, formed by the merger last year of life science tools companies Applied Biosystems and Invitrogen, has an estimated 65% of the market for PCR machines used for research and has licensed its technology to 12 other companies making the machines.
FORBES: Technology